People
-
The University of Western Ontario has named particle technology researcher Jesse Zhu a 2012 Distinguished University Professorship winner. Zhu, a professor and Canada Research Chair in Powder Technology Applications in the Department of Chemical and… Read more . . .
-
Hovione has appointed Colin Minchom, formerly Patheon’s VP of Pharmaceutical Development Services for North America, as VP of its Particle Design Business Unit. Minchom has almost 30 years experience in drug development, especially in dosage… Read more . . .
-
Powder characterization specialist Freeman Technology has established a US subsidiary, Freeman Technology Inc., to handle the growing North American demand for its FT4 powder rheometer. Newly-hired National Sales Specialist Mike Delancey and Applications Specialist John… Read more . . .
-
Inhalation testing specialist Frank Chambers has launched a new analytical consultancy specializing in OINDP testing called Inhalytic. Chambers, whose most recent position was as Senior Scientist at AstraZeneca, where he performed analytical research on inhaler… Read more . . .
-
Prosonix has announced the appointment of Geoff Down to the newly-created position of Chief Medical Officer, effective immediately. Down, who has extensive experience in clinical development and has served various roles, some as a consultant… Read more . . .
-
Team Consulting has announced two new hires: Mark Shepherd, formerly Physical Properties Scientist in respiratory product development at GSK, and Human Factors and User Research Consultant Ben Cox. Shepherd, who has experience with dry powder… Read more . . .
-
SkyePharma CEO Axel Mueller has resigned “to pursue other interests,” according to the company, and will be replaced by current Chief Financial Officer Peter Grant. The company’s announcement says that Grant, who has been CFO… Read more . . .
-
Contract research organization Melbourn Scientific has announced the promotion of Derek Solomon to Operations Director, effective immediately. Solomon, who joined the company in 2005, previously held the title of Laboratory Manager and oversaw Melbourn’s addition… Read more . . .
-
As UK-based Prosonix transitions from a particle engineering specialist into a pharmaceutical company with three inhaled respiratory drugs in its pipeline, it has announced the appointment of Rob Crocker as its first Head of Regulatory… Read more . . .
-
MAP Pharmaceuticals has appointed W. James O’Shea, a former President and COO of Sepracor, to its board of directors. During eight years at Sepracor, O’Shea held a number of positions in operations and commercialization and… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal